MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/591529

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2008

Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.

Wormser Gary P, Liveris Dionysios, Hanincová Klára, Brisson Dustin, Ludin Sara, Stracuzzi Vincent J, Embers Monica E, Philipp Mario T, Levin Andrew, Aguero-Rosenfeld Maria, Schwartz Ira

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

A potential concern with any serologic test to detect antibodies to Borrelia burgdorferi is whether the epitopes incorporated in the test provide sufficient cross-reactivity to detect infection with all of the pathogenic strains of the species. This is a particular concern for the C6 test, which is based on reactivity to a single peptide.

METHODS

C6 testing and 2-tier testing were performed on acute-phase serum samples obtained from >158 patients with erythema migrans for whom the genotype of the borrelial isolate was defined on the basis of an analysis of the 16S-23S ribosomal DNA spacer region and/or on the genetic variation of the outer surface protein C gene (ospC). The sonicated whole cell-based enzyme-linked immunosorbent assay, the immunoblots used in the 2-tier testing, and the C6 assay all used antigens from B. burgdorferi sensu stricto strain B31.

RESULTS

The sensitivity of C6 testing (69.5%) was greater than that of 2-tier testing (38.9%) (P<.001); the difference in sensitivity, however, was statistically significant only for patients infected with 2 of the 3 ribosomal spacer type-defined genotypes. The lower sensitivity of 2-tier testing was attributable to the low sensitivity of the immunoblot tests, rather than the first-tier enzyme-linked immunosorbent assay. There was also a trend for the sensitivity of 2-tier testing to vary according to the ospC genotype for the 14 genotypes represented in the study (P=.07); this relationship was not observed with C6 testing.

CONCLUSIONS

Lack of sensitivity of the C6 test because of strain diversity seems less likely to be a limitation of this serologic test, compared with 2-tier testing in North American patients with early Lyme disease.

Для цитирования: Wormser Gary P, Liveris Dionysios, Hanincová Klára, Brisson Dustin, Ludin Sara, Stracuzzi Vincent J, Embers Monica E, Philipp Mario T, Levin Andrew, Aguero-Rosenfeld Maria, Schwartz Ira. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008. DOI: 10.1086/591529.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.